Home
Products
Learn
About
Pricing
Log In
ITCI

This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.

Asset Logo

Intra-Cellular Therapies, Inc.

๐Ÿ‡บ๐Ÿ‡ธ NYSE/NASDAQ

๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ’ต Cost

๐Ÿƒ Esg

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

+ 162.39%
Annual Growth

5 years average annual capital growth

๐ŸŒ

2
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

Intra-Cellular Therapies, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders. The Company leverages intracellular approach to develop treatments for people living with complex psychiatric and neurologic diseases. The Companyโ€™s product, CAPLYTA (lumateperone), is an oral, once daily atypical antipsychotic approved in adults for the treatment of schizophrenia and the treatment of depressive episodes associated with bipolar I or II disorder (bipolar depression) as monotherapy and as adjunctive therapy with lithium or valproate. Its pipeline includes several product candidates in clinical development and additional product candidates in non-clinical testing, such as ITI-1284-ODT-SL program, Phosphodiesterase type I inhibitor (PDE1) program, ITI-333 program, and ITI-1500 Non-Hallucinogenic Psychedelic program. ITI-1284 is a deuterated form of lumateperone, a new chemical entity.

๐Ÿ“ˆ Performance

Price History*

+446.27%

1M

1Y

10Y

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

N/A
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿค“ Advanced information

Technical Info

๐Ÿ’ฐ Price*

$131.87

*Price may be up to 24 hours old

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in ITCI

0

๐Ÿ“Š Total Capital Earnings

N/A

๐Ÿ”ƒ Average investment frequency

7 days

๐Ÿ’ต Average investment amount

$90

โฐ Last time a customer invested in ITCI

60 days
ITCI investor breakdown
๐Ÿ’ต Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

๐Ÿ‘ถ Age of investors

18 - 25

26 - 34

35 - 90

๐Ÿ™‹ Legal gender of investors

Female

Male

Pearlers who invest in ITCI also invest in...

Eli Lilly and Company

LLY

๐Ÿ™Œ Performance (5Yr p.a)

74.53%

๐Ÿ“Š Share price

$746.06 USD
Find Out More

๐Ÿ™Œ Performance (5Yr p.a)

43.76%

๐Ÿ“Š Share price

$24.77 USD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿ™Œ Performance (5Yr p.a)

314.09%

๐Ÿ“Š Share price

$129.93 USD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿ™Œ Performance (5Yr p.a)

34.47%

๐Ÿ“Š Share price

$327.32 USD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿ™Œ Performance (5Yr p.a)

314.11%

๐Ÿ“Š Share price

$38.89 USD

Want more shares? Try these...

๐Ÿ“Š Share price

$3.10 USD

๐Ÿ“Š Share price

$0.02 USD